FDA Recall Terminated

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.

Recall: Z-0417-2015 · Initiated October 16, 2014

Recall

Recall Number
Z-0417-2015
Event Number
69545
Firm
Diagnostic Hybrids Inc
FEI Number
1000122536
Product Code
JZH
Status
Terminated
Root Cause
Device Design
Initiated
October 16, 2014
Posted
September 3, 2015
Terminated
September 3, 2015
Address
1055 E State St, Suite 100, Athens, OH, 45701-7911

Description

MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform the test. In vitro diagnostic.

Reason

Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically documented.

Action

Quidel sent an Urgent Medical Device Recall letter dated October 16, 2014, to all consignees. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to immediately review their inventory and determine if they have of the affected product. If so, they should remove it from their inventory and destroy it immediately by discarding it into their normal biomedical waste stream. Complete the enclosed Certificate of Destruction. Upon receipt of the Certificate of Destruction, Quidel, will then schedule their shipment of replacement product. If consignees further distributed the affected product, they should identify the customers and provide them with the Urgent Medical Device Recall. Consignees were instructed to monitor and reconcile the quarantine of product with the customers as this information may need to be provided to the authorities. For questions regarding this recall call 740-589-3300. For technical support consignees should contact [email protected] or call 800-874-1517.

Distribution

Worldwide Distribution - USA, including AL, CO, CT, FL, KY, MN, NC, NV, OH, PA, and WA; and, the countries of Canada, China, India, and Switzerland.

Quantity

171